Bayer’s Drug ‘Eylea’ Successful With Diabetic Macular Degeneration

Picture_of_brown_eyes

According to Bayer, which co-developed the drug along with Regeneron, the drug VEGF Trap-Eye, also known as Eylea, has reached goals established by the companies during year-long, Phase 3 trials.

Read more

Posted in Drugs